Literature DB >> 19116350

Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR.

Mingjun Jiang1, Janet G Baseman, Laura A Koutsky, Qinghua Feng, Constance Mao, Nancy B Kiviat, Long Fu Xi.   

Abstract

Given that the integration of human papillomavirus type 16 (HPV16) into the host genome occurs preferentially with the disruption of the E2 gene, a ratio of E2 to E7 gene copies is often used as a marker for integration. It is largely undetermined, however, whether ratio estimates are affected by HPV intratypic variations. We assembled four plasmid constructs, each containing a DNA fragment from an HPV16 European, Asian-American, African-1, or African-2 variant. These constructs and nine cervical swab samples were assayed by real-time PCR with two primer-probe sets for each gene: a specific set, fully complementary to the HPV16 prototype, and a degenerate set, incorporating degenerate bases at positions where nucleotides differed among the variants. The ratio of E2 to E7 gene copies for the European variant construct was close to 1, no matter which sets of primers and probes were used. While the ratios for the African-1 and Asian-American variant constructs remained close to 1 with the degenerate sets of primers and probes, the ratios were 0.36 and 2.57, respectively, with the specific sets of primers and probes. In addition, a nucleotide alteration at the position immediately following the 3' end of the E2 forward primer binding site was found to be responsible for an underestimation of E2 gene copies for the African-2 variant construct. Similar patterns were found in nine cervical samples. In conclusion, mismatches between the primers and probes and their targets due to HPV16 intratypic variations would introduce errors in testing for integration; this situation can be sufficiently ameliorated by incorporating degenerate bases into the primers and probes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116350      PMCID: PMC2650947          DOI: 10.1128/JCM.02115-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.

Authors:  William Alazawi; Mark Pett; Barbara Arch; Laurie Scott; Tom Freeman; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique.

Authors:  Panu Peitsaro; Bo Johansson; Stina Syrjänen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions.

Authors:  S A Tonon; M A Picconi; P D Bos; J B Zinovich; J Galuppo; L V Alonio; A R Teyssie
Journal:  J Clin Virol       Date:  2001-05       Impact factor: 3.168

4.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

5.  Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes.

Authors:  Mark R Pett; William O F Alazawi; Ian Roberts; Sally Dowen; David I Smith; Margaret A Stanley; Nicholas Coleman
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

Review 6.  Environmental co-factors in HPV carcinogenesis.

Authors:  Xavier Castellsagué; F Xavier Bosch; Nubia Muñoz
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

7.  Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions.

Authors:  Monica Cricca; Antonio Maria Morselli-Labate; Simona Venturoli; Simone Ambretti; Giovanna Angela Gentilomi; Giorgio Gallinella; Silvano Costa; Monica Musiani; Marialuisa Zerbini
Journal:  Gynecol Oncol       Date:  2007-06-13       Impact factor: 5.482

8.  Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

Authors:  Shalini L Kulasingam; James P Hughes; Nancy B Kiviat; Constance Mao; Noel S Weiss; Jane M Kuypers; Laura A Koutsky
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

9.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

Review 10.  Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

Authors:  Sophia S Wang; Allan Hildesheim
Journal:  J Natl Cancer Inst Monogr       Date:  2003
View more
  2 in total

1.  Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women.

Authors:  Rachel L Winer; Long Fu Xi; Zhenping Shen; Joshua E Stern; Laura Newman; Qinghua Feng; James P Hughes; Laura A Koutsky
Journal:  Int J Cancer       Date:  2013-10-18       Impact factor: 7.396

2.  Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.

Authors:  Saloua Kahla; Lotfi Kochbati; Samia Hammami; Mohamed Badis Chanoufi; Mongi Maalej; Ridha Oueslati
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.